Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study
NCT00184496
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
DRUG:
Methadone
Sponsor
Norwegian University of Science and Technology